BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38478958)

  • 1. Changes in vaccine coverage and incidence of acute gastroenteritis and severe rotavirus gastroenteritis in children <5 years in Shibata City, Niigata Prefecture, Japan.
    Oishi T; Hasegawa S; Nakano T; Sudo S; Kuwajima H; Tokuriki S; Tamura T
    Hum Vaccin Immunother; 2024 Dec; 20(1):2322202. PubMed ID: 38478958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence of severe rotavirus gastroenteritis in children younger than three years of age before and after the introduction of rotavirus vaccine: a prospective observational study in four pediatric clinics in Shibata City, Niigata Prefecture, Japan.
    Oishi T; Matsunaga M; Nakano T; Sudo S; Kuwajima H; Tokuriki S; Study SR
    Hum Vaccin Immunother; 2020 Oct; 16(10):2495-2501. PubMed ID: 32609565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The occurrence of severe rotavirus gastroenteritis in children under 3 years of age before and after the introduction of rotavirus vaccine: a prospective observational study in three pediatric clinics in Shibata City, Niigata Prefecture, Japan.
    Oishi T; Taguchi T; Nakano T; Sudo S; Kuwajima H;
    Jpn J Infect Dis; 2014; 67(4):304-6. PubMed ID: 25056079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of rotavirus vaccination on the burden of acute gastroenteritis in Nagoya city, Japan.
    Yoshikawa T; Matsuki T; Sato K; Mizuno M; Shibata M; Hasegawa S; Morita M; Iwasa M; Gopala K; Holl K
    Vaccine; 2018 Jan; 36(4):527-534. PubMed ID: 29248263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rotavirus gastroenteritis hospitalization rates and correlation with rotavirus vaccination coverage in Sicily.
    Restivo V; Caracci F; Sannasardo CE; Scarpitta F; Vella C; Ventura G; Tramuto F; Costantino C
    Acta Biomed; 2018 Oct; 89(3):437-442. PubMed ID: 30333453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained reduction in rotavirus-coded hospitalizations in children aged <5 years after introduction of self-financed rotavirus vaccines in Japan.
    Kobayashi M; Miyazaki M; Ogawa A; Tatsumi M
    Hum Vaccin Immunother; 2020; 16(1):132-137. PubMed ID: 31298962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term surveillance of rotavirus vaccination after implementation of a national immunization program in Finland (2008-2018).
    Hemming-Harlo M; Gylling A; Herse F; Haavisto I; Nuutinen M; Pasternack M; Kanibir MN; Hartwig S; Carias C
    Vaccine; 2022 Jun; 40(29):3942-3947. PubMed ID: 35641360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of monovalent and pentavalent rotavirus vaccines in Japanese children.
    Araki K; Hara M; Tsugawa T; Shimanoe C; Nishida Y; Matsuo M; Tanaka K
    Vaccine; 2018 Aug; 36(34):5187-5193. PubMed ID: 30037664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of rotavirus vaccine in reducing hospitalization rates in pediatric patients: a single center experience in Italy.
    Dettori S; Cortesia I; Mariani M; Opisso A; Mesini A; Saffioti C; Castagnola E
    Hum Vaccin Immunother; 2021 Dec; 17(12):5646-5649. PubMed ID: 34766869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rotavirus gastroenteritis hospitalizations in provinces with different vaccination coverage rates in Spain, 2013-2018.
    Ruiz-Contreras J; Alfayate-Miguelez S; Carazo-Gallego B; Onís E; Díaz-Munilla L; Mendizabal M; Méndez Hernández M; Ferrer-Lorente B; Unsaín-Mancisidor M; Ramos-Amador JT; Croche-Santander B; Centeno Malfaz F; Rodríguez-Suárez J; Cotarelo M; San-Martín M; Arístegui J
    BMC Infect Dis; 2021 Nov; 21(1):1138. PubMed ID: 34742235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of rotavirus gastroenteritis hospitalizations and genotypes, before and five years after introducing universal immunization in Israel.
    Muhsen K; Kassem E; Rubenstein U; Goren S; Ephros M; Cohen D; Shulman LM
    Vaccine; 2016 Nov; 34(48):5916-5922. PubMed ID: 27771186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute gastroenteritis hospitalizations after implementation of universal mass vaccination against rotavirus.
    Kõivumägi K; Toompere K; Soeorg H; Kallas E; Jõgeda EL; Huik K; ; Lutsar I
    Vaccine; 2020 Mar; 38(13):2879-2886. PubMed ID: 32067818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary care-based surveillance to estimate the proportion of rotavirus gastroenteritis among Latvian children below 5 years of age with acute gastroenteritis.
    Tafalla M; Gardovska D; Gopala K; Kozlovska L
    Hum Vaccin Immunother; 2019; 15(6):1272-1278. PubMed ID: 30335570
    [No Abstract]   [Full Text] [Related]  

  • 14. The changes of the epidemiology and clinical characteristics of rotavirus gastroenteritis-associated convulsion after the introduction of rotavirus vaccine.
    Kawase M; Hoshina T; Yoneda T; Kojiro M; Takahashi Y; Kusuhara K
    J Infect Chemother; 2020 Mar; 26(3):206-210. PubMed ID: 31563335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of rotavirus vaccine on all-cause acute gastroenteritis and rotavirus hospitalizations in Israel: A nationwide analysis.
    Muhsen K; Haklai Z; Applbaum Y; Gordon ES; Shteiman A; Glatman-Freedman A; Leshem E
    Vaccine; 2020 Feb; 38(10):2406-2415. PubMed ID: 32029322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rotavirus genotypes and clinical outcome of natural infection based on vaccination status in the post-vaccine era.
    Kozawa K; Higashimoto Y; Kawamura Y; Miura H; Negishi T; Hattori F; Ihira M; Komoto S; Taniguchi K; Yoshikawa T
    Hum Vaccin Immunother; 2022 Dec; 18(1):2037983. PubMed ID: 35240934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact and effectiveness of RotaTeq® vaccine based on 3 years of surveillance following introduction of a rotavirus immunization program in Finland.
    Vesikari T; Uhari M; Renko M; Hemming M; Salminen M; Torcel-Pagnon L; Bricout H; Simondon F
    Pediatr Infect Dis J; 2013 Dec; 32(12):1365-73. PubMed ID: 24051998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of effectiveness of universal rotavirus vaccination in Southwestern Vietnam based on a dynamic mathematical model.
    Lee T; Kang JM; Ahn JG; Thuy Truong DT; Nguyen TV; Ho TV; Thanh Ton HT; Le Hoang P; Kim MY; Yeom JS; Lee J
    Sci Rep; 2024 Feb; 14(1):4273. PubMed ID: 38383679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Socioeconomic Impact of the Rotavirus Vaccine in Korea: Comparing the Epidemiologic and Economic Characteristics of Rotavirus Gastroenteritis Before and After the Introduction of Vaccines.
    Cho H; Lee H; Kim DS; Kim HM; Kim JH; Kim AY; Kang HY
    Pediatr Infect Dis J; 2020 May; 39(5):460-465. PubMed ID: 31990891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hospital-based surveillance of rotavirus gastroenteritis in the era of limited vaccine uptake through the private sector.
    Trimis G; Koutsoumbari I; Kottaridi C; Palaiologou N; Assimakopoulou E; Spathis A; Lebessi E; Konstantopoulos A; Kafetzis D; Karakitsos P; Papaevangelou V
    Vaccine; 2011 Oct; 29(43):7292-5. PubMed ID: 21816195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.